Abstract
Polikistik over sendromu üreme çağındaki kadınlarda yaygın olarak görülen, kadınların tüm yaşam alanlarını etkileyen endokrin bir hastalık olup aynı zamanda etiyolojiye bağlı olarak çevresel faktörlerden de etkilenen bir hastalıktır. Polikistik over sendromunun tedavisinde medikal, cerrahi ya da destekleyici yöntemler kullanılmaktadır. Kanıta dayalı uygulamalar ve kanıta dayalı hemşirelik bakımı son yıllarda gelişme göstermektedir. Profesyonel bir meslek olan hemşirelerin bakım uygulamalarında kanıta dayalı güncel verileri kullanmaları gerekmektedir. Kanıta dayalı güncel veriler doğrultusunda bakım verilen hastaların yaşam kaliteleri de olumlu yönde etkilenmektedir. Bu derleme, polikistik over sendromu olan hastaların tanı, tedavi ve bakımına yönelik güncel kanıta dayalı uygulamaları ortaya koymak amacıyla yazılmıştır.
Supporting Institution
Herhangi bir kurumdan destek alınmamıştır.
References
- Referans1. Golden SH, Karen AR, Saldanha I, Anton B, Ladenson PW. Prevalence and incidence of endocrine and metabolic disorders in the United States: a comprehensive review. J Clin Endocrinol Metab. 2009; 94(6): 1853-1878.
- Referans2. The American Collage of Obstetricians and Gynecologists (ACOG). Available from: https://www.acog.org/womens-health/faqs/polycystic-ovary-syndrome-pcos Accessed: 05.02.2021
- Referans3. Ak Yıldırım H, Memişoğulları R. Polikistik over sendromu’nda gözlenen biyokimyasal bozukluklar. Konuralp Tıp Dergisi. 2011; 3(1), 42-48.
- Referans4. Tehrani FR, Simbar M, Tohidi M, Hosseinpanah F, Azizi F. The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study. Reprod Biol Endocrinol. 2011; 9(39): 1-7.
- Referans5. Mehrabian F, Khani B, Kelishadi R, Ghanbari E. The prevalence of polycystic ovary syndrome in Iranian women based on different diagnostic criteria. Endokrynol Pol. 2011; 62(3): 238–242.
- Referans6. Kumarapeli V, Seneviratne AR, Wijeyaratne CN, Yapa RM, Dodampahala SH. A simple screening approach to assess community prevalence and phenotype of polycystic ovary syndrome in a semi-urban population in Sri Lanka. Am J Epidemiol. 2008: 168(3); 321–328.
- Referans7. Asuncion M, Calvo RM., San Millan JL, Sancho J, Avila S, Escobar-Morreale HF. A prospective study of the prevalence of polycystic ovary syndrome in non-selected Caucasian women from Spain. J Clin Endocrinol Metab. 2000: 85(7); 2434–2438.
- Referans8. Musmar S, Afaneh A, Mo'alla H. Epidemiology of polycystic ovary syndrome: A cross-sectional study of university students at the National University of An-Najah-Palestine. Reprodroductive Biology and Endocrinology, 2013; 11(47): 1-6.
- Referans9. Sharif E, Rahman S, Zia Y, Rizk NM. The frequency of polycystic ovary syndrome in young reproductive females in Qatar. Int J Womens Health. 2017; 9: 1-10.
- Referans10. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab. 2004; 89(6): 2745– 2749.
- Referans11. 11. Yava A, Tosun N, Çiçek H, Yavan T, Terakye G, Hatipoğlu S. Hemşirelerin araştırma sonuçlarını kullanımında engeller ölçeğinin geçerlilik ve güvenilirliği. Gülhane Tıp Dergisi. 2007; 49: 72–79.
- Referans12. Dinçer Y, Şanlı Y, Kızılkaya Beji N. İnfertilite hemşireliğinde kanıta dayalı yaklaşımlar. Androloji Bülteni. 2015; 17(63); 289-295.
- Referans13. Kocaman G. Hemşirelikte Kanıta Dayalı Uygulama. Hemşirelikte Araştırma Geliştirme Dergisi. 2003; 5(2): 61–67.
- Referans14. International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome 2018. Available from: https://www.monash.edu/__data/assets/pdf_file/0004/1412644/PCOS_Evidence-Based-Guidelines_20181009.pdf Accessed: 05.02.2021
- Referans15. Kadıoğlu M, Kızılkaya Beji N. Polikistik over sendromu ve hemşirelik yaklaşımı. Florence Nightinagle Hemşirelik Dergisi. 2013; 21(3): 187-197.
- Referans16. Alataş E, Kılıç D, Güler T. Güncel polikistik over sendromu değerlendirme ve yönetim rehberi doğrultusunda tanıdaki ‘yeniler’ ve ‘yineler’. Pamukkale Tıp Dergisi. 2019; 12(3): 595-602.
- Referans17. Aherna SA. Polycystic ovary syndrome. Nurs Stand. 2004; 18(26): 40–44.
- Referans18. Kelley, L. (2003). Polycystic ovarian syndrom: A challenge for occupational health nursing. AAOHN J. 2003; 51(1): 23–27.
Abstract
Polycystic ovary syndrome is an endocrine disease that is common in women of reproductive age and affects all
life spheres of women, and also is a disease that is affected by environmental factors depending on the
etiology. Medical, surgical or supportive methods are used in the treatment of polycystic ovary syndrome. In order
for individuals with polycystic ovary syndrome to obtain the best benefit from their treatment and care, the
practices of healthcare professionals must be based on the strongest evidence. Evidence-based practices and
evidence-based nursing care have developed in recent years. As a profession, nurses are required to use up-todate evidence-based data in their care practices. In line with the evidence-based current data, the life quality
of patients who receive care is also positively affected. This review has been written to reveal current evidencebased practices for the diagnosis, treatment, and care of patients with polycystic ovary syndrome.
References
- Referans1. Golden SH, Karen AR, Saldanha I, Anton B, Ladenson PW. Prevalence and incidence of endocrine and metabolic disorders in the United States: a comprehensive review. J Clin Endocrinol Metab. 2009; 94(6): 1853-1878.
- Referans2. The American Collage of Obstetricians and Gynecologists (ACOG). Available from: https://www.acog.org/womens-health/faqs/polycystic-ovary-syndrome-pcos Accessed: 05.02.2021
- Referans3. Ak Yıldırım H, Memişoğulları R. Polikistik over sendromu’nda gözlenen biyokimyasal bozukluklar. Konuralp Tıp Dergisi. 2011; 3(1), 42-48.
- Referans4. Tehrani FR, Simbar M, Tohidi M, Hosseinpanah F, Azizi F. The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study. Reprod Biol Endocrinol. 2011; 9(39): 1-7.
- Referans5. Mehrabian F, Khani B, Kelishadi R, Ghanbari E. The prevalence of polycystic ovary syndrome in Iranian women based on different diagnostic criteria. Endokrynol Pol. 2011; 62(3): 238–242.
- Referans6. Kumarapeli V, Seneviratne AR, Wijeyaratne CN, Yapa RM, Dodampahala SH. A simple screening approach to assess community prevalence and phenotype of polycystic ovary syndrome in a semi-urban population in Sri Lanka. Am J Epidemiol. 2008: 168(3); 321–328.
- Referans7. Asuncion M, Calvo RM., San Millan JL, Sancho J, Avila S, Escobar-Morreale HF. A prospective study of the prevalence of polycystic ovary syndrome in non-selected Caucasian women from Spain. J Clin Endocrinol Metab. 2000: 85(7); 2434–2438.
- Referans8. Musmar S, Afaneh A, Mo'alla H. Epidemiology of polycystic ovary syndrome: A cross-sectional study of university students at the National University of An-Najah-Palestine. Reprodroductive Biology and Endocrinology, 2013; 11(47): 1-6.
- Referans9. Sharif E, Rahman S, Zia Y, Rizk NM. The frequency of polycystic ovary syndrome in young reproductive females in Qatar. Int J Womens Health. 2017; 9: 1-10.
- Referans10. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab. 2004; 89(6): 2745– 2749.
- Referans11. 11. Yava A, Tosun N, Çiçek H, Yavan T, Terakye G, Hatipoğlu S. Hemşirelerin araştırma sonuçlarını kullanımında engeller ölçeğinin geçerlilik ve güvenilirliği. Gülhane Tıp Dergisi. 2007; 49: 72–79.
- Referans12. Dinçer Y, Şanlı Y, Kızılkaya Beji N. İnfertilite hemşireliğinde kanıta dayalı yaklaşımlar. Androloji Bülteni. 2015; 17(63); 289-295.
- Referans13. Kocaman G. Hemşirelikte Kanıta Dayalı Uygulama. Hemşirelikte Araştırma Geliştirme Dergisi. 2003; 5(2): 61–67.
- Referans14. International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome 2018. Available from: https://www.monash.edu/__data/assets/pdf_file/0004/1412644/PCOS_Evidence-Based-Guidelines_20181009.pdf Accessed: 05.02.2021
- Referans15. Kadıoğlu M, Kızılkaya Beji N. Polikistik over sendromu ve hemşirelik yaklaşımı. Florence Nightinagle Hemşirelik Dergisi. 2013; 21(3): 187-197.
- Referans16. Alataş E, Kılıç D, Güler T. Güncel polikistik over sendromu değerlendirme ve yönetim rehberi doğrultusunda tanıdaki ‘yeniler’ ve ‘yineler’. Pamukkale Tıp Dergisi. 2019; 12(3): 595-602.
- Referans17. Aherna SA. Polycystic ovary syndrome. Nurs Stand. 2004; 18(26): 40–44.
- Referans18. Kelley, L. (2003). Polycystic ovarian syndrom: A challenge for occupational health nursing. AAOHN J. 2003; 51(1): 23–27.
Details
| Primary Language | Turkish |
|---|---|
| Subjects | Health Care Administration |
| Journal Section | Review |
| Authors | |
| Publication Date | June 30, 2021 |
| Acceptance Date | June 1, 2021 |
| Published in Issue | Year 2021 Volume: 30 Issue: 2 |
